Everything below concerns prescription control. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Pharmacologically, melanotan-2 behaves as a non-selective agonist across the melanocortin receptor family. Binding at MC1R on dermal melanocytes promotes eumelanin synthesis, which underlies the tanning response described in early human work. Activity at the centrally expressed MC4R receptor is associated with reported effects on appetite and erectile function. Because the peptide does not discriminate strongly among receptor subtypes, attributing any single observed effect to one receptor pathway is generally not possible without selective antagonists or receptor knockout models.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Regulatory status differs by country, and in many places supplying the compound for human consumption is unlawful. Vendors frequently label material as intended for research use only, a designation that shifts stated purpose but does not create a legal pathway for personal use. Certificates of analysis accompanying such products vary widely in detail and provenance. Third-party testing exists but is voluntary, and results are rarely linked to a specific lot in a publicly verifiable way.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Melanotan II; MT-II; N-acetyl-norleucyl-cyclo[Asp-His-D-Phe-Arg-Trp-Lys] amide | Naming follows peptide convention; the numeral distinguishes it from melanotan-1 |
| Molecular formula | C50H69N15O9 | Includes the lactam bridge; no counter-ion assumed |
| Monoisotopic mass | 1023.53 Da | Free base; salts and counter-ions shift the observed value |
| Appearance | White to off-white lyophilised powder | Batch-to-batch colour variation is not itself proof of impurity |
| Typical analytical method | RP-HPLC purity determination with ESI-MS identity confirmation | Retention time alone does not establish sequence identity |
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Meyerowitz expanded this rhetoric through a series of publications that sought to reconstruct early history. She claimed that Akan origins and culture came from areas in the Sahara and the Near East, and argued that Akan culture was not mainly black African, but could instead be considered Libya-Berber or connected to Mediterranean or Near Eastern cultures.
Richard F. Edlich (January 19, 1939, New York City, New York – December 25, 2013, Brush Prairie, Washington) was a Professor Emeritus of Plastic Surgery, Biomedical Engineering and Emergency Medicine at the University of Virginia Health System. His basic clinical and research interests focused on improving the safety and outcome of wound care in emergency medicine and surgery.
=== Kynurenine/tryptophan ratio === Changes in the ratio of kynurenine versus tryptophan are reported for many diseases like arthritis, HIV/AIDS, neuropsychiatric disorders, cancer and inflammations. The kynurenin/tryptophan is also an indicator for the activity of indoleamine 2,3-dioxygenase (IDO).
The Rutgers team reported streptomycin in the medical literature in January 1944. Within months they began working with William Feldman and H. Corwin Hinshaw of the Mayo Clinic with hopes of starting a human clinical trial of streptomycin in tuberculosis. The difficulty at first was even producing enough streptomycin to do a trial, because the research laboratory methods of creating small batches had not yet been translated to commercial large-batch production. They managed to do an animal study in a few guinea pigs with just 10 grams of the scarce drug, demonstrating survival. This was just enough evidence to get Merck & Co. to divert some resources from the young penicillin production program to start work toward streptomycin production. At the end of World War II, the United States Army experimented with streptomycin to treat life-threatening infections at a military hospital in Battle Creek, Michigan. The first person who was treated with streptomycin did not survive; the second person survived but became blind as a side effect of the treatment. In March 1946, the third person—Robert J. Dole, later Majority Leader of the United States Senate and presidential nominee—experienced a rapid and robust recovery. The first randomized trial of streptomycin against pulmonary tuberculosis was carried out in 1946 through 1948 by the MRC Tuberculosis Research Unit under the chairmanship of Geoffrey Marshall (1887–1982). The trial was neither double-blind nor placebo-controlled. It is widely accepted to have been the first randomized curative trial.
Quantities of liquids are measured in units of volume. These include the SI unit cubic metre (m3) and its divisions, in particular the cubic decimeter, more commonly called the litre (1 dm3 = 1 L = 0.001 m3), and the cubic centimetre, also called millilitre (1 cm3 = 1 mL = 0.001 L = 10−6 m3). The volume of a quantity of liquid is fixed by its temperature and pressure. Liquids generally expand when heated, and contract when cooled. Water between 0 °C and 4 °C is a notable exception. On the other hand, liquids have little compressibility. Water, for example, will compress by only 46.4 parts per million for every unit increase in atmospheric pressure (bar). At around 4000 bar (400 megapascals or 58,000 psi) of pressure at room temperature water experiences only an 11% decrease in volume. Incompressibility makes liquids suitable for transmitting hydraulic power, because a change in pressure at one point in a liquid is transmitted undiminished to every other part of the liquid and very little energy is lost in the form of compression. However, the negligible compressibility does lead to other phenomena. The banging of pipes, called water hammer, occurs when a valve is suddenly closed, creating a huge pressure-spike at the valve that travels backward through the system at just under the speed of sound. Another phenomenon caused by liquid's incompressibility is cavitation. Because liquids have little elasticity they can literally be pulled apart in areas of high turbulence or dramatic change in direction, such as the trailing edge of a boat propeller or a sharp corner in a pipe.
Sources: en.wikipedia.org
Lyon, Davor Solter and Azim Surani, for their pioneering work on epigenetic gene regulation in mammalian embryos 2005 Martin Chalfie and Roger Y. Tsien, for their pioneering development of powerful new tools that allow the direct visualization of molecules in living cells 2004 Andrew Z. Fire, Craig C. Mello, Victor Ambros and Gary Ruvkun, for their pioneering achievements in the discovery of gene silencing by double-stranded RNA 2003 Masakazu Konishi, Peter Marler and Fernando Nottebohm, for their pioneering achievements in the ethology and neurology of birdsong 2002 Ira Herskowitz, for his pioneering achievements in yeast genetics and cell biology 2001 Joan A. Steitz, for her work in establishing a sub-field of molecular biology concerning small nuclear ribonucleoproteins 2000 Peter B. Moore, Harry F. Noller, Jr. and Thomas A. Steitz, for their discovery that peptide bond formation on the ribosome is catalyzed exclusively by ribosomal RNA 1999 Roderick MacKinnon, for his research into the molecular foundations of electrical signal generation in neurons and other types of cells 1998 Elizabeth Blackburn and Carol Greider, for their outstanding work on the maintenance of telomeres 1997 H. Robert Horvitz and John E. Sulston, for their pioneering studies of cell lineage in the nematode worm 1996 Richard Axel, Linda B. Buck and A. James Hudspeth, for establishing the molecular basis of the senses of smell and hearing 1995 Thomas D. Pollard and James A. Spudich, for their fundamental contributions to our understanding of molecular motors 1994 Robert G.
Centrifugal partition chromatography requires only a biphasic mixture of solvents, so by varying the constitution of the solvent system it is possible to tune the partition coefficients of different compounds so that separation is guaranteed by the high selectivity.
Claire fixes up his wound and a bond develops between the two; she allows McCormick to stay, and he and Nat later build a simulated bomber-plane cockpit in Nat's treehouse so that McCormick can teach Nat how to fly. McCormick passes out and is hospitalized, where he discovers his body is failing as his age begins to catch up to him. McCormick tracks down Finley's daughter Susan, who informs him her father died in a lab fire before she was born. The FBI discovers there was a warehouse lab fire in the early 40s, and all the scientists including Finley died trying to save the frozen McCormick from the chaos. In the aftermath of the fire, people mistook the cryonics chamber for a water heater, not knowing that McCormick was inside, resulting in him being accidentally frozen for 53 years. She gives McCormick her father's journals, detailing the cryogenic process, and Finley's notes disclose that the rapid aging is irreversible. Susan also reveals that Helen is still alive, but they escape before the FBI, who is now after McCormick, catch up to them. Claire drives McCormick to an air show where he commandeers a B-25 bomber to fly to Helen's seaside-lighthouse home, with Nat stowing away on board. Claire gives Harry's journals to the FBI, for their plans to replicate and modernize the experiment. McCormick suffers another aging attack, forcing Nat (who is now slightly familiar with the plane's controls after his simulated-training session with McCormick) to land the plane in the field near Helen's house.
=== Benign prostatic hyperplasia and prostate cancer === Dutasteride is used for treating BPH, colloquially known as an "enlarged prostate". It is approved by the Food and Drug Administration (FDA) in the U.S. for this indication. A 2010 Cochrane review found a 25–26% reduction in the risk of developing prostate cancer with 5α-reductase inhibitor chemoprevention.
Sources: en.wikipedia.org
=== Number average molar mass === The number average molar mass is a way of determining the molecular mass of a polymer. Polymer molecules, even ones of the same type, come in different sizes (chain lengths, for linear polymers), so the average molecular mass will depend on the method of averaging. The number average molecular mass is the ordinary arithmetic mean or average of the molecular masses of the individual macromolecules. It is determined by measuring the molecular mass of n polymer molecules, summing the masses, and dividing by n.
Cited half-life: the median age of the articles that were cited in Journal Citation Reports each year. For example, if a journal's half-life in 2005 is 5, that means the citations from 2001 to 2005 are half of all the citations from that journal in 2005, and the other half of the citations precede 2001. Aggregate impact factor for a subject category: it is calculated taking into account the number of citations to all journals in the subject category and the number of articles from all the journals in the subject category. Immediacy index: the number of citations the articles in a journal receive in a given year divided by the number of articles published. Journal citation indicator (JCI): a JIF that adjusts for scientific field; it is similar to Source Normalized Impact per Paper, calculated based on the Scopus database. JCI is available for all journals in the Web of Science Core Collection (WoS CC)—including the AHCI, ESCI, BCI, CPCI—while JIF is only available for the SCIE and SSCI; however, starting in June 2023, JIF will also be issued for all journals in the WoS CC. JIF quartile ranking: a rank based on the four quartiles within a given subject or topic category. JIF percentile ranking: a percentile rank computed for a particular subject category. A given journal may attain a different quartile or percentile in different categories. As with the impact factor, there are some nuances to this: for example, Clarivate excludes certain article types (such as news items, correspondence, and errata) from the denominator.
=== Absorption === Estradiol is well-absorbed regardless of route of administration. However, the bioavailability of estradiol differs substantially with different routes of administration. Oral estradiol has an average bioavailability of around 5%, requiring relatively high dosages of estradiol for effects. Estradiol administered in the form of an ester by intramuscular or subcutaneous injection has complete bioavailability.
=== Amino acid metabolism === Clostridium scindens also has the genetic potential to perform Stickland fermentation, or the generation of ATP through the fermentation of amino acids. C. scindens pairs amino acid fermentation with bile acid metabolism by using amino acids as electron donors and primary bile acids as acceptors. The presence of glycine and proline reductase enzymes in the Clostridium scindens ATCC35704 genome indicates that glycine and proline may be commonly fermented amino acids by this organism.
In 1979, the ANC's National Executive Committee had indeed endorsed a programme which included mass popular mobilisation inside South Africa, and its literature contained calls to reject the black local authorities. In addition, ANC president Oliver Tambo famously called for opponents of apartheid to make South Africa "ungovernable". On 8 January 1984, Tambo's annual statement to ANC members had included the entreaty:We should direct our collective might to rendering the enemy's instruments of authority unworkable. To march forward must mean that we advance against the regime's organs of state-power, creating conditions in which the country becomes increasingly ungovernable... Having rejected the community councils by boycotting the elections, we should not allow them to be imposed on us. We do not want them. We must ensure that they cease to exist. Where administration boards take over their functions, then these must be destroyed too.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.
The natural hormone is a linear tridecapeptide that is rapidly degraded in circulation. Melanotan-2 is shortened, cyclised, N-terminally acetylated, and carries a D-amino acid substitution, all of which slow enzymatic breakdown.
No national medicines regulator has approved melanotan-2 for therapeutic or cosmetic use. In several jurisdictions it is treated as an unapproved prescription medicine, and its legal classification differs from country to country.
Dry powder is usually held frozen, shielded from light, and kept away from moisture. Desiccant packaging limits hydrolysis during storage. Solutions are typically aliquoted and frozen once, because repeated thawing shortens useful life.